Related Experiment Video
Updated: Aug 8, 2026

08:15
A Hepatocellular Cancer Patient-Derived Organoid Xenograft Model to Investigate Impact of Liver Regeneration on Tumor Growth
Published on: February 2, 2024
Predictors for Recurrence in Hepatoblastoma: Single-center Study
Lajja Jivani1, M M Zameer1, Vinay Chandrashekar1
1Department of Pediatric Surgery, Narayana Health, Bengaluru, Karnataka, India.
Journal of Indian Association of Pediatric Surgeons
|August 7, 2026
Summary
Vascular involvement and liver transplantation are key predictors of hepatoblastoma recurrence in children. These factors significantly impact survival, highlighting the need for refined risk-stratified management strategies.
Area of Science:
- Pediatric Oncology
- Surgical Oncology
- Hepatobiliary Surgery
Background:
- Hepatoblastoma is the most common pediatric liver cancer.
- Multimodal therapy has improved survival, but recurrence remains a challenge.
Purpose of the Study:
- To identify risk factors for hepatoblastoma recurrence after hepatic resection.
- To evaluate the association of various factors with tumor recurrence and survival.
Main Methods:
- Retrospective study of 25 children undergoing hepatic resection for hepatoblastoma.
- Analysis of eight potential risk factors including vascular involvement and liver transplantation.
- Follow-up included AFP levels and imaging; statistical analysis used Fisher's exact test.
Main Results:
- Tumor recurrence observed in 20% of patients, primarily as distant metastases.
- Vascular involvement (P=0.038) and need for liver transplantation (P=0.016) were significantly associated with recurrence.
- Overall survival was 88%, but significantly lower (40%) in patients with recurrence.
Conclusions:
- Vascular involvement and liver transplantation are significant predictors of hepatoblastoma recurrence.
- Factors like age, AFP, PRETEXT stage, histology, surgical margin, and SIOPEL high-risk category were not associated with recurrence.
- Recurrence is linked to increased mortality, necessitating further research for risk-stratified management.